市場調査レポート
商品コード
1062854

薬事業務アウトソーシングの市場規模・シェア・動向分析 (2022-2030年):カテゴリー (生物製剤・医療機器)・企業規模 (中規模・大規模)・適応症・ステージ・サービス・エンドユーザー別

Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Category (Biologics, Medical Devices), By Company Size (Medium, Large), By Indication, By Stage, By Services, By End Use, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
薬事業務アウトソーシングの市場規模・シェア・動向分析 (2022-2030年):カテゴリー (生物製剤・医療機器)・企業規模 (中規模・大規模)・適応症・ステージ・サービス・エンドユーザー別
出版日: 2022年02月16日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬事業務アウトソーシングの市場規模は予測期間中8.9%のCAGRで推移し、2030年には139億米ドルの規模に成長すると予測されています。

トレーニング、技術、専門知識、施設など、薬事業務やオペレーションに必要な社内リソースの固定費が大幅に増加していることが、薬事業務のアウトソーシングを推進する要因となっています。また、米国、欧州、アジアなどの主要市場において、各国の規制上の課題や規制の絶え間ない変更に対応することも、これらのサービスに対する需要を生み出しています。

当レポートでは、世界の薬事業務アウトソーシングの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、サービス・企業規模・カテゴリー・ステージ・適応症・エンドユーザー・産業・地域/主要国など各種区分別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 薬事業務アウトソーシング市場の可変因子・動向・展望

  • 市場の分類・範囲
  • 市場力学
  • 普及・成長の見通しマッピング
  • 業界の課題
  • 主要な取引と戦略的提携の分析
  • 規制関連:市場分析ツール

第4章 薬事業務アウトソーシング市場:サービス別の分析

  • 市場シェア分析
  • 規制コンサルティング
  • 法定代理人
  • 薬事関連の執筆・出版
  • 製品登録・臨床試験申請
  • その他のサービス

第5章 薬事業務アウトソーシング市場:企業規模別の分析

  • 市場シェア分析
  • 小規模企業
  • 中規模企業
  • 大規模企業

第6章 薬事業務アウトソーシング市場:カテゴリー別の分析

  • 市場シェア分析
  • 薬物
  • 生物製剤
  • 医療機器

第7章 薬事業務アウトソーシング市場:ステージ別の分析

  • 市場シェア分析
  • 前臨床
  • 臨床
  • PMA

第8章 薬事業務アウトソーシング市場:適応症別の分析

  • 市場シェア分析
  • 腫瘍
  • 神経
  • 心臓病
  • 免疫
  • その他の適応症

第9章 薬事業務アウトソーシング市場:エンドユーザー別の分析

  • 市場シェア分析
  • 医療機器企業
  • 製薬企業
  • バイオテクノロジー企業

第10章 薬事業務アウトソーシング市場:地域別の分析

  • 市場シェア分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 企業プロファイル

  • Accell Clinical Research, LLC.
  • GenPact Ltd.
  • Criterium, Inc.
  • PRA Health Sciences
  • Promedica International
  • WuXi AppTec, Inc.
  • Medpace
  • Charles River Laboratories International, Inc.
  • ICON plc
  • Covance
  • PAREXEL International Corporation, Inc.
  • Freyr
  • Pharmalex GMBH
  • NDA Group AB
  • Pharmexon Consulting s.r.o
  • Qvigilance
  • BlueReg Group
  • Cambridge Regulatory Services
  • APCER Life Sciences, Inc
  • Real Regulatory Ltd.
  • Voisin Consulting Life Sciences
  • PrimeVigilance
  • ProPharma Group MIS Limited
  • Regulatory Pharma Net srl
  • Zeincro Group
  • BioMapas
  • Dr. Regenold GmbH
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Regulatory Affairs Outsourcing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 6 Global Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 7 Global Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 8 Global Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 9 Global Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 10 Global Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 11 Global Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 12 Global Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 North America Regulatory Affairs Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 14 North America Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 15 North America Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 16 North America Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 17 North America Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 18 North America Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 19 North America Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 20 North America Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 21 North America Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 22 North America Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 U.S. Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 24 U.S. Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 25 U.S. Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 26 U.S. Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 27 U.S. Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 28 U.S. Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 29 U.S. Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 30 U.S. Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 31 U.S. Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Canada Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Canada Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 34 Canada Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 35 Canada Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 36 Canada Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 37 Canada Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 38 Canada Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 39 Canada Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 40 Canada Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Europe Regulatory Affairs Outsourcing Market, by Country, 2018 - 2030 (USD Million)
  • Table 42 Europe Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Europe Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 44 Europe Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 45 Europe Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 46 Europe Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 47 Europe Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 48 Europe Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 49 Europe Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 50 Europe Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 51 U.K. Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 52 U.K. Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 53 U.K. Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 54 U.K. Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 55 U.K. Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 56 U.K. Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 57 U.K. Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 58 U.K. Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 59 U.K. Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Germany Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 61 Germany Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 62 Germany Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 63 Germany Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 64 Germany Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 65 Germany Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Germany Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 67 Germany Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 68 Germany Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 69 France Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 70 France Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 71 France Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 72 France Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 73 France Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 74 France Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 75 France Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 76 France Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 77 France Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 78 Italy Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 79 Italy Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 80 Italy Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 81 Italy Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 82 Italy Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 83 Italy Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 84 Italy Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 85 Italy Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 86 Italy Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Spain Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 88 Spain Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 89 Spain Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 90 Spain Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 91 Spain Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 92 Spain Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 93 Spain Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 94 Spain Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 95 Spain Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 96 Russia Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 97 Russia Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 98 Russia Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 99 Russia Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 100 Russia Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 101 Russia Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 102 Russia Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 103 Russia Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 104 Russia Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 105 Turkey Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 106 Turkey Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 107 Turkey Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 108 Turkey Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 109 Turkey Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 110 Turkey Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 111 Turkey Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 112 Turkey Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 113 Turkey Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 114 The Netherlands Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 115 The Netherlands Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 116 The Netherlands Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 117 The Netherlands Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 118 The Netherlands Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 119 The Netherlands Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 120 The Netherlands Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 121 The Netherlands Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 122 The Netherlands Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 123 Switzerland Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 124 Switzerland Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 125 Switzerland Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 126 Switzerland Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 127 Switzerland Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 128 Switzerland Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 129 Switzerland Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 130 Switzerland Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 131 Switzerland Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 132 Sweden Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 133 Sweden Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 134 Sweden Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 135 Sweden Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 136 Sweden Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 137 Sweden Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 138 Sweden Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 139 Sweden Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 140 Sweden Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 141 Europe CIS Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 142 Europe CIS Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 143 Europe CIS Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 144 Europe CIS Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 145 Europe CIS Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 146 Europe CIS Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 147 Europe CIS Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 148 Europe CIS Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 149 Europe CIS Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 150 Asia Pacific Regulatory Affairs Outsourcing Market, by Region, 2018 - 2030 (USD Million)
  • Table 151 Asia Pacific Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 152 Asia Pacific Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 153 Asia Pacific Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 154 Asia Pacific Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 155 Asia Pacific Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 156 Asia Pacific Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 157 Asia Pacific Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 158 Asia Pacific Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 159 Asia Pacific Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 160 Japan Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 161 Japan Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 162 Japan Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 163 Japan Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 164 Japan Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 165 Japan Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 166 Japan Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 167 Japan Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 168 Japan Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 169 China Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 170 China Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 171 China Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 172 China Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 173 China Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 174 China Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 175 China Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 176 China Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 177 China Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 178 India Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 179 India Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 180 India Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 181 India Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 182 India Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 183 India Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 184 India Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 185 India Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 186 India Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 187 Australia Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 188 Australia Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 189 Australia Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 190 Australia Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 191 Australia Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 192 Australia Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 193 Australia Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 194 Australia Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 195 Australia Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 196 South Korea Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 197 South Korea Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 198 South Korea Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 199 South Korea Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 200 South Korea Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 201 South Korea Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 202 South Korea Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 203 South Korea Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 204 South Korea Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 205 Indonesia Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 206 Indonesia Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 207 Indonesia Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 208 Indonesia Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 209 Indonesia Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 210 Indonesia Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 211 Indonesia Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 212 Indonesia Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 213 Indonesia Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 214 Malaysia Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 215 Malaysia Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 216 Malaysia Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 217 Malaysia Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 218 Malaysia Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 219 Malaysia Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 220 Malaysia Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 221 Malaysia Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 222 Malaysia Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 223 Singapore Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 224 Singapore Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 225 Singapore Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 226 Singapore Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 227 Singapore Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 228 Singapore Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 229 Singapore Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 230 Singapore Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 231 Singapore Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 232 Thailand Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 233 Thailand Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 234 Thailand Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 235 Thailand Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 236 Thailand Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 237 Thailand Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 238 Thailand Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 239 Thailand Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 240 Thailand Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 241 Taiwan Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 242 Taiwan Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 243 Taiwan Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 244 Taiwan Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 245 Taiwan Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 246 Taiwan Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 247 Taiwan Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 248 Taiwan Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 249 Taiwan Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 250 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 251 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 252 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 253 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 254 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)
  • Table 255 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Indication, 2018 - 2030 (USD Million)
  • Table 256 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Stage, 2018 - 2030 (USD Million)
  • Table 257 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table 258 Asia Pacific CIS Regulatory Affairs Outsourcing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 259 Latin America Regulatory Affairs Outsourcing Market, by Region, 2018 - 2030 (USD Million)
  • Table 260 Latin America Regulatory Affairs Outsourcing Market, by Service, 2018 - 2030 (USD Million)
  • Table 261 Latin America Regulatory Affairs Outsourcing Market, by Category, 2018 - 2030 (USD Million)
  • Table 262 Latin America Regulatory Affairs Outsourcing Market, by Drugs, 2018 - 2030 (USD Million)
  • Table 263 Latin America Regulatory Affairs Outsourcing Market, by Biologics, 2018 - 2030 (USD Million)
  • Table 264 Latin America Regulatory Affairs Outsourcing Market, by Medical Device, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Regulatory affairs outsourcing market snapshot (2020)
  • Fig. 9 Regulatory affairs outsourcing market segmentation
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Number of Trials, By WHO Regions
  • Fig. 12 Personalized Medicine as a percentage of CDER approved novel molecules.
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 SWOT
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Regulatory affairs outsourcing market service outlook: Segment dashboard
  • Fig. 19 Regulatory affairs outsourcing market: service movement analysis
  • Fig. 20 Regulatory consulting market, 2018 - 2030 (USD Million)
  • Fig. 21 Legal representation market, 2018 - 2030 (USD Million)
  • Fig. 22 Regulatory writing and publishing market, 2018 - 2030 (USD Million)
  • Fig. 23 Product registration and clinical trial application market, 2018 - 2030 (USD Million)
  • Fig. 24 Other regulatory services market, 2018 - 2030 (USD Million)
  • Fig. 25 Regulatory affairs outsourcing market company size outlook: Segment dashboard
  • Fig. 26 Regulatory affairs outsourcing market: Company Size movement analysis
  • Fig. 27 Small companies based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 28 Medium sized company based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 29 Large companies based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 30 Regulatory affairs outsourcing market categories outlook: Segment dashboard
  • Fig. 31 Regulatory affairs outsourcing market: Categories movement analysis
  • Fig. 32 Drugs based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 33 Generics based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 34 Innovator based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 35 Biologics based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 36 Biotech based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 37 ATMPs based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 38 Biosimilar based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 39 Medical devices based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostics based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 41 Therapeutic based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 42 Regulatory affairs product stage outlook: Segment dashboard
  • Fig. 43 Regulatory affairs outsourcing market: Product Stage movement analysis
  • Fig. 44 Preclinical based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 45 Clinical based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 46 PMA based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 47 Regulatory affairs outsourcing market indication outlook: Segment dashboard
  • Fig. 48 Regulatory affairs outsourcing market: indication movement analysis
  • Fig. 49 Oncology based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 50 Neurology based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 51 Cardiology based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 52 Immunology indication based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 53 Other indication based regulatory affairs outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 54 Regulatory affairs outsourcing market end-use outlook: Segment dashboard
  • Fig. 55 Regulatory affairs outsourcing market: end-use movement analysis
  • Fig. 56 Medical device companies market, 2018 - 2030 (USD Million)
  • Fig. 57 Pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 58 Biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 59 Regional market: Key takeaways
  • Fig. 60 Regional outlook, 2020 & 2028
  • Fig. 61 North America market, 2018 - 2030 (USD Million)
  • Fig. 62 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 63 Canada market, 2018 - 2030 (USD Million)
  • Fig. 64 Europe market, 2018 - 2030 (USD Million)
  • Fig. 65 UK market, 2018 - 2030 (USD Million)
  • Fig. 66 Germany market, 2018 - 2030 (USD Million)
  • Fig. 67 France market, 2018 - 2030 (USD Million)
  • Fig. 68 Italy market, 2018 - 2030 (USD Million)
  • Fig. 69 Spain market, 2018 - 2030 (USD Million)
  • Fig. 70 Russia market, 2018 - 2030 (USD Million)
  • Fig. 71 Turkey market, 2018 - 2030 (USD Million)
  • Fig. 72 Netherlands market, 2018 - 2030 (USD Million)
  • Fig. 73 Switzerland market, 2018 - 2030 (USD Million)
  • Fig. 74 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 75 Europe CIS market, 2018 - 2030 (USD Million)
  • Fig. 76 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 77 Japan market, 2018 - 2030 (USD Million)
  • Fig. 78 China market, 2018 - 2030 (USD Million)
  • Fig. 79 India market, 2018 - 2030 (USD Million)
  • Fig. 80 Australia market, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 82 Indonesia market, 2018 - 2030 (USD Million)
  • Fig. 83 Malaysia market, 2018 - 2030 (USD Million)
  • Fig. 84 Singapore market, 2018 - 2030 (USD Million)
  • Fig. 85 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 86 Taiwan market, 2018 - 2030 (USD Million)
  • Fig. 87 Asia Pacific CIS market, 2018 - 2030 (USD Million)
  • Fig. 88 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 89 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 90 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 91 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 92 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 93 Chile market, 2018 - 2030 (USD Million)
  • Fig. 94 MEA market, 2018 - 2030 (USD Million)
  • Fig. 95 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 96 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 97 UAE market, 2018 - 2030 (USD Million)
  • Fig. 98 Egypt market, 2018 - 2030 (USD Million)
  • Fig. 99 Israel market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-556-4

Regulatory Affairs Outsourcing Market Growth & Trends:

The global regulatory affairs outsourcing market size is expected to reach USD 13.9 billion by 2030, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Significant increase in the fixed costs of in-house resources for regulatory affairs & operation activities like training, technology, specialized knowledge, and facilities are driving outsourcing of regulatory affair functions. Addressing local regulatory challenges and constant changes in the regulations of the major markets, such as the U.S., Europe, and Asia, is creating demand for these services. Compliance with the current regulations has become an immense chore, leave alone trying to stay up to date with developments around the world. Amendments to current regulations are likely to simplify the regulatory pathway for the industry but in turn, complicate the operation for healthcare product manufacturing companies.

Thus, leading to the regulatory affairs outsourcing to service providers. The market witnessed a significant decline in 2020 due to the outbreak of the COVID-19 pandemic, as there was a halt in clinical trial activities including regulatory updates. Disruption in the supply chain and closure of R&D sites resulted in a significant loss of revenues in 2020 across the industry. However, due to the pandemic, various healthcare companies are opting for more regulatory advice, as companies push to speed up the product development & approvals in therapies, vaccines, & devices for COVID-19. Owing to the urgent need for medical devices and therapies for COVID-19, regulatory authorities are providing emergency use authorization for the majority of products. Such actions have further promoted the demand for these services post 2020 and the positive rebound of sales across the industry can be witnessed from 2021.

Regulatory Affairs Outsourcing Market Report Highlights:

  • The regulatory writing & publishing services segment dominated the market with the maximum revenue share in 2021as they are offered from the early stages of development to the post-marketing authorization phase and are vital for the success of a product
  • The large companies segment is projected to witness the fastest CAGR during the forecast period. The availability of a wide variety of services and the presence of these providers in various geographies are the key factors driving the segment growth
  • The clinical studies stage segment accounted for the largest market share in 2021 due to the increasing demand for clinical trials in developing countries
  • The pharmaceutical companies end-use segment is anticipated to witness the fastest growth rate over the forecast period due to evolving areas, such as orphan drugs and personalized therapies
  • Asia Pacific held the maximum revenue share of the global market in 2021 owing to higher off shoring of such services into regions of economic benefits and the expansion of life sciences companies in countries, such as India & China

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Services
    • 1.1.2. Company Size
    • 1.1.3. Category
    • 1.1.4 Indication
    • 1.1.5 Stage
    • 1.1.6 End User
    • 1.1.7 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Region Wise Market Calculation
    • 1.6.1 Region Wise Market: Base Estimates
    • 1.6.2 Global Market: CAGR Calculation
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective - 1: Understanding market dynamics
    • 1.8.2 Objective - 2: Understanding market estimates and forecasts
    • 1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
    • 1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Regulatory Affairs Outsourcing Market: Variables, Trends, & Scope

  • 3.1 Market Segmentation and Scope
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Changing regulatory landscape
      • 3.2.1.2 Entry of companies in the global market
      • 3.2.1.3 Life science companies focusing on their core competencies
      • 3.2.1.4 Economic and competitive pressures
      • 3.2.1.5 Demand for faster approval process for breakthrough drugs and devices
      • 3.2.1.6 Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Risk associated with data security
      • 3.2.2.2 Monitoring issues and lack of standardization
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Industry Challenges
    • 3.4.1 Managing Relationships
  • 3.5 Major Deals and Strategic Alliances Analysis
  • 3.6 Regulatory Affairs: Market Analysis Tools
    • 3.6.1 SWOT
    • 3.6.2 Industry Analysis - Porter's
    • 3.6.3 PESTEL Analysis

Chapter 4 Regulatory Affairs Outsourcing Market: Service Segment Analysis

  • 4.1 Regulatory Affairs Outsourcing Market: Service Market Share Analysis, 2020 & 2028
  • 4.2 Regulatory Consulting
    • 4.2.1 Regulatory Consulting Market, 2018 - 2030 (USD Million)
  • 4.3 Legal Representation
    • 4.3.1 Legal Representation Market, 2018 - 2030 (USD Million)
  • 4.4 Regulatory Writing and Publishing
    • 4.4.1 Regulatory Writing and Publishing Market, 2018 - 2030 (USD Million)
  • 4.5 Product Registration and Clinical Trial Application
    • 4.5.1 Product Registration and Clinical Trial Application Market, 2018 - 2030 (USD Million)
  • 4.6 Other Services
    • 4.6.1 Other Services Market, 2018 - 2030 (USD Million)

Chapter 5 Regulatory Affairs Outsourcing Market: Company Size Segment Analysis

  • 5.1 Regulatory Affairs Outsourcing Market: Company Size Market Share Analysis, 2020 & 2028
  • 5.2 Small Sized Companies
    • 5.2.1 Small Sized Companies Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 5.3 Medium Sized Companies
    • 5.3.1 Medium Sized Companies Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 5.4 Large Sized Companies
    • 5.4.1 Large Companies Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 6 Regulatory Affairs Outsourcing Market: Categories Segment Analysis

  • 6.1 Regulatory Affairs Outsourcing Market: Categories Market Share Analysis, 2020 & 2028
  • 6.2 Drugs
    • 6.2.1 Drugs Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.2.2 Generics
      • 6.2.2.1 Generics Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.2.3 Innovator
      • 6.2.3.1 Innovator Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 6.3 Biologics
    • 6.3.1 Biologics Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.3.2 Biotech
      • 6.3.2.1 Biotech Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.3.3 ATMPs
      • 6.3.3.1 ATMPs Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.3.4 Biosimilars
      • 6.3.4.1 Biosimilar Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 6.4 Medical Devices
    • 6.4.1 Medical Devices Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.4.2 Diagnostics
      • 6.4.2.1 Diagnostics Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 6.4.3 Therapeutics
      • 6.4.3.1 Therapeutics Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 7 Regulatory Affairs Outsourcing Market: Stage Segment Analysis

  • 7.1 Regulatory Affairs Market: Stage Market Share Analysis, 2020 & 2028
  • 7.2 Preclinical
    • 7.2.1 Preclinical-based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 7.3 Clinical
    • 7.3.1 Clinical-based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 7.4 PMA
    • 7.4.1 PMA-based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 8 Regulatory Affairs Outsourcing Market: Indication Segment Analysis

  • 8.1 Regulatory Affairs Outsourcing Market: Indication Market Share Analysis, 2020 & 2028
  • 8.2 Oncology
    • 8.2.1 Oncology Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 8.3 Neurology
    • 8.3.1 Neurology Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 8.4 Cardiology
    • 8.4.1 Cardiology Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 8.5 Immunology
    • 8.5.1 Immunology Indication Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (Usd Million)
  • 8.6 Other Indications
    • 8.6.1 Other Indication Based Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 9 Regulatory Affairs Outsourcing Market: End-use Segment Analysis

  • 9.1 Regulatory Affairs Outsourcing Market: End-use Market Share Analysis, 2020 & 2028
  • 9.2 Medical Device Companies
    • 9.2.1 Medical Device Companies Market, 2018 - 2030 (USD Million)
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 9.4 Biotechnology Companies
    • 9.4.1 Biotechnology Companies Market, 2018 - 2030 (USD Million)

Chapter 10 Regulatory Affairs Outsourcing Market: Regional Analysis

  • 10.1 Regulatory Affairs Outsourcing Market: Regional Market Share Analysis, 2020 & 2028
  • 10.2 North America
    • 10.2.1 North America Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.2.2 U.S.
      • 10.2.2.1 U.S. Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.2.3 Canada
      • 10.2.3.1 Canada Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 10.3 Europe
    • 10.3.1 Europe Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.2 U.K.
      • 10.3.2.1 U.K. Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.3 Germany
      • 10.3.3.1 Germany Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.4 France
      • 10.3.4.1 France Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.5 Italy
      • 10.3.5.1 Italy Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.6 Spain
      • 10.3.6.1 Spain Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.7 Russia
      • 10.3.7.1 Russia Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.8 Turkey
      • 10.3.8.1 Turkey Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.9 The Netherlands
      • 10.3.9.1The Netherlands Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.10 Switzerland
      • 10.3.10.1 Switzerland Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.11 Sweden
      • 10.3.11.1 Sweden Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.3.12 CIS Countries
      • 10.3.12.1 CIS Countries Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.2 Japan
      • 10.4.2.1 Japan Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.3 China
      • 10.4.3.1 China Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.4 India
      • 10.4.4.1 India Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.5 Australia
      • 10.4.5.1 Australia Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.6 South Korea
      • 10.4.6.1 South Korea Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.7 Indonesia
      • 10.4.7.1 Indonesia Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.8 Malaysia
      • 10.4.8.1 Malaysia Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.9 Singapore
      • 10.4.9.1 Singapore Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.10 Thailand
      • 10.4.10.1 Thailand Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.11 Taiwan
      • 10.4.11.1 Taiwan Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.4.12 CIS Countries
      • 10.4.12.1 Taiwan Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Latin America Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.5.2 Brazil
      • 10.5.2.1 Brazil Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.5.3 Mexico
      • 10.5.3.1 Mexico Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.5.4 Argentina
      • 10.5.4.1 Argentina Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.5.5 Colombia
      • 10.5.5.1 Colombia Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.5.6 Chile
      • 10.5.6.1 Chile Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
  • 10.6 MEA
    • 10.6.1 MEA Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.6.2 South Africa
      • 10.6.2.1 South Africa Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.6.3 Saudi Arabia
      • 10.6.3.1 Saudi Arabia Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.6.4 UAE
      • 10.6.4.1 UAE Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.6.5 Egypt
      • 10.6.5.1 Egypt Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)
    • 10.6.6 Israel
      • 10.6.6.1 Israel Regulatory Affairs Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 11 Company Profiles

  • 11.1 Accell Clinical Research, LLC.
    • 11.1.1 Company Overview
    • 11.1.2 Service Benchmarking
    • 11.1.3 Geographic Presence
    • 11.1.4 Strategic Intiatives
    • 11.1.5 SWOT
  • 11.2 GenPact Ltd.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Service Benchmarking
    • 11.2.4 Geographic Presence
    • 11.2.5 Strategic Initiatives
    • 11.2.6 SWOT
  • 11.3 Criterium, Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Service Benchmarking
    • 11.3.3 Geographic Presence
    • 11.3.4 Swot
  • 11.4 PRA Health Sciences
    • 11.4.1 Company Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Service Benchmarking
    • 11.4.4 Geographic Presence
    • 11.4.5 Strategic Initiatives
    • 11.4.6 SWOT
  • 11.5 Promedica International
    • 11.5.1 Company Overview
    • 11.5.2 Service Benchmarking
    • 11.5.3 Geographic Presence
    • 11.5.4 SWOT
  • 11.6 WuXi AppTec, Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Service Benchmarking
    • 11.6.4 Geographic Presence
    • 11.6.5 Strategic Initiatives
    • 11.6.6 SWOT
  • 11.7 Medpace
    • 11.7.1 Company Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Service Benchmarking
    • 11.7.4 Geographic Presence
    • 11.7.5 Swot
  • 11.8 Charles River Laboratories International, Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Service Benchmarking
    • 11.8.4 Geographic Presence
    • 11.8.5 Strategic Initiatives
    • 11.8.6 SWOT
  • 11.9 ICON plc
    • 11.9.1 Company Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Service Benchmarking
    • 11.9.4 Geographic Presence
    • 11.9.5 Strategic Initiatives
    • 11.9.6 SWOT
  • 11.10 Covance
    • 11.10.1 Company Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Service Benchmarking
    • 11.10.4 Geographic Presence
    • 11.10.5 Strategic Initiatives
    • 11.10.6 SWOT
  • 11.11 PAREXEL International Corporation, Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Service Benchmarking
    • 11.11.4 Geographic Presence
    • 11.11.5 Strategic Initiatives
    • 11.11.6 SWOT
  • 11.12 Freyr
    • 11.12.1 Company Overview
    • 11.12.2 Service Benchmarking
    • 11.12.3 Geographic Presence
    • 11.12.4 Strategic Initiatives
    • 11.12.5 SWOT
  • 11.13 Pharmalex GMBH
    • 11.13.1 Company Overview
    • 11.13.2 Service Benchmarking
    • 11.13.3 Geographic Presence
    • 11.13.4 Strategic Initiatives
    • 11.13.5 SWOT
  • 11.14 NDA Group AB
    • 11.14.1 Company Overview
    • 11.14.2 Service Benchmarking
    • 11.14.3 Geographic Presence
    • 11.14.4 SWOT
  • 11.15 Pharmexon Consulting s.r.o
    • 11.15.1 Company Overview
    • 11.15.2 Service Benchmarking
    • 11.15.3 SWOT
  • 11.16 Qvigilance
    • 11.16.1 Company Overview
    • 11.16.2 Service Benchmarking
    • 11.16.3 SWOT
  • 11.17 BlueReg Group
    • 11.17.1 Company Overview
    • 11.17.2 Service Benchmarking
    • 11.17.3 Geographic Presence
    • 11.17.4 Strategic Initiatives
    • 11.17.5 SWOT
  • 11.18 Cambridge Regulatory Services
    • 11.18.1 Company Overview
    • 11.18.2 Service Benchmarking
    • 11.18.3 SWOT
  • 11.19 APCER Life Sciences, Inc
    • 11.19.1 Company Overview
    • 11.19.2 Service Benchmarking
    • 11.19.3 Geographic Presence
    • 11.19.4 Strategic Initiatives
    • 11.19.5 SWOT
  • 11.20 Real Regulatory Ltd.
    • 11.20.1 Company Overview
    • 11.20.2 Service Benchmarking
    • 11.20.3 SWOT
  • 11.21 Voisin Consulting Life Sciences
    • 11.21.1 Company Overview
    • 11.21.2 Service Benchmarking
    • 11.21.3 Geographic Presence
    • 11.21.4 Strategic Initiatives
    • 11.21.5 SWOT
  • 11.22 PrimeVigilance
    • 11.22.1 Company Overview
    • 11.22.2 Service Benchmarking
    • 11.22.3 Geographic Presence
    • 11.22.4 Strategic Initiatives
    • 11.22.5 SWOT
  • 11.23 ProPharma Group MIS Limited
    • 11.23.1 Company overview
    • 11.23.2 Service Benchmarking
    • 11.23.3 Geographic Presence
    • 11.23.4 Strategic Initiatives
    • 11.23.5 SWOT
  • 11.24 Regulatory Pharma Net srl
    • 11.24.1 Company Overview
    • 11.24.2 Service Benchmarking
    • 11.24.3 Geographic Presence
    • 11.24.4 SWOT
  • 11.25 Zeincro Group
    • 11.25.1 Company Overview
    • 11.25.2 Service Benchmarking
    • 11.25.3 Geographic Presence
    • 11.25.4 Strategic Initiatives
    • 11.25.5 SWOT
  • 11.26 BioMapas
    • 11.26.1 Company Overview
    • 11.26.2 Service Benchmarking
    • 11.26.3 Geographic Presence
    • 11.26.4 Strategic Initiatives
    • 11.26.5 SWOT
  • 11.27 Dr. Regenold GmbH
    • 11.27.1 Company Overview
    • 11.27.2 Service Benchmarking
    • 11.27.3 SWOT